161 related articles for article (PubMed ID: 33859085)
1. Peters Anomaly in Nail-Patella Syndrome: A Case Report and Clinico-Genetic Correlation.
Ramappa M; Gandhi U; Chaurasia S; Kabra M; Kaur I; Mittal R; Mishra DK; Chakrabarti S; Edward DP
Cornea; 2021 Nov; 40(11):1487-1490. PubMed ID: 33859085
[TBL] [Abstract][Full Text] [Related]
2. Whole exome sequence analysis of Peters anomaly.
Weh E; Reis LM; Happ HC; Levin AV; Wheeler PG; David KL; Carney E; Angle B; Hauser N; Semina EV
Hum Genet; 2014 Dec; 133(12):1497-511. PubMed ID: 25182519
[TBL] [Abstract][Full Text] [Related]
3. Foxe3 haploinsufficiency in mice: a model for Peters' anomaly.
Ormestad M; Blixt A; Churchill A; Martinsson T; Enerbäck S; Carlsson P
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1350-7. PubMed ID: 11980846
[TBL] [Abstract][Full Text] [Related]
4. A novel small deletion of LMX1B in a large Chinese family with nail-patella syndrome.
Yan X; Lin J; Wang Y; Xuan J; Yu P; Guo T; Jin F
BMC Med Genet; 2019 May; 20(1):71. PubMed ID: 31053111
[TBL] [Abstract][Full Text] [Related]
5. LMX1B mutation with residual transcriptional activity as a cause of isolated glomerulopathy.
Isojima T; Harita Y; Furuyama M; Sugawara N; Ishizuka K; Horita S; Kajiho Y; Miura K; Igarashi T; Hattori M; Kitanaka S
Nephrol Dial Transplant; 2014 Jan; 29(1):81-8. PubMed ID: 24042019
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of LMX1B mutations associated with nail-patella syndrome.
Sato U; Kitanaka S; Sekine T; Takahashi S; Ashida A; Igarashi T
Pediatr Res; 2005 Jun; 57(6):783-8. PubMed ID: 15774843
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy.
Harita Y; Kitanaka S; Isojima T; Ashida A; Hattori M
Pediatr Nephrol; 2017 Oct; 32(10):1845-1850. PubMed ID: 27450397
[TBL] [Abstract][Full Text] [Related]
8. c.194 A>C (Q65P) mutation in the LMX1B gene in patients with nail-patella syndrome associated with glaucoma.
Romero P; Sanhueza F; Lopez P; Reyes L; Herrera L
Mol Vis; 2011; 17():1929-39. PubMed ID: 21850167
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic characterization of nephropathy in patients with nail-patella syndrome.
Harita Y; Urae S; Akashio R; Isojima T; Miura K; Yamada T; Yamamoto K; Miyasaka Y; Furuyama M; Takemura T; Gotoh Y; Takizawa H; Tamagaki K; Ozawa A; Ashida A; Hattori M; Oka A; Kitanaka S
Eur J Hum Genet; 2020 Oct; 28(10):1414-1421. PubMed ID: 32457516
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome.
Vollrath D; Jaramillo-Babb VL; Clough MV; McIntosh I; Scott KM; Lichter PR; Richards JE
Hum Mol Genet; 1998 Jul; 7(7):1091-8. PubMed ID: 9618165
[TBL] [Abstract][Full Text] [Related]
11. 8q21.11 microdeletion in two patients with syndromic peters anomaly.
Happ H; Schilter KF; Weh E; Reis LM; Semina EV
Am J Med Genet A; 2016 Sep; 170(9):2471-5. PubMed ID: 27378168
[TBL] [Abstract][Full Text] [Related]
12. Internal Carotid Artery Aplasia in a Patient With Nail-Patella Syndrome.
Kraus J; Jahngir MU; Singh B; Qureshi AI
Vasc Endovascular Surg; 2020 Feb; 54(2):175-181. PubMed ID: 31746280
[TBL] [Abstract][Full Text] [Related]
13. A familial case of nail patella syndrome with a heterozygous in-frame indel mutation in the LIM domain of LMX1B.
Mukai M; Fujita H; Umegaki-Arao N; Sasaki T; Yasuda-Sekiguchi F; Isojima T; Kitanaka S; Amagai M; Kubo A
J Dermatol Sci; 2018 Apr; 90(1):90-93. PubMed ID: 29290531
[TBL] [Abstract][Full Text] [Related]
14. Clinico-genetic study of nail-patella syndrome.
Lee BH; Cho TJ; Choi HJ; Kang HK; Lim IS; Park YH; Ha IS; Choi Y; Cheong HI
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S82-6. PubMed ID: 19194568
[TBL] [Abstract][Full Text] [Related]
15. Novel variants in CDH2 are associated with a new syndrome including Peters anomaly.
Reis LM; Houssin NS; Zamora C; Abdul-Rahman O; Kalish JM; Zackai EH; Plageman TF; Semina EV
Clin Genet; 2020 Mar; 97(3):502-508. PubMed ID: 31650526
[TBL] [Abstract][Full Text] [Related]
16. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys.
Heidet L; Bongers EM; Sich M; Zhang SY; Loirat C; Meyrier A; Broyer M; Landthaler G; Faller B; Sado Y; Knoers NV; Gubler MC
Am J Pathol; 2003 Jul; 163(1):145-55. PubMed ID: 12819019
[TBL] [Abstract][Full Text] [Related]
17. A family with Axenfeld-Rieger syndrome and Peters Anomaly caused by a point mutation (Phe112Ser) in the FOXC1 gene.
Honkanen RA; Nishimura DY; Swiderski RE; Bennett SR; Hong S; Kwon YH; Stone EM; Sheffield VC; Alward WL
Am J Ophthalmol; 2003 Mar; 135(3):368-75. PubMed ID: 12614756
[TBL] [Abstract][Full Text] [Related]
18. Could the interaction between LMX1B and PAX2 influence the severity of renal symptoms?
Negrisolo S; Carraro A; Fregonese G; Benetti E; Schaefer F; Alberti M; Melchionda S; Fischetto R; Giordano M; Murer L
Eur J Hum Genet; 2018 Nov; 26(11):1708-1712. PubMed ID: 29973660
[TBL] [Abstract][Full Text] [Related]
19. Nail-Patella Syndrome: clinical and molecular data in 55 families raising the hypothesis of a genetic heterogeneity.
Ghoumid J; Petit F; Holder-Espinasse M; Jourdain AS; Guerra J; Dieux-Coeslier A; Figeac M; Porchet N; Manouvrier-Hanu S; Escande F
Eur J Hum Genet; 2016 Jan; 24(1):44-50. PubMed ID: 25898926
[TBL] [Abstract][Full Text] [Related]
20. Mutation of WIF1: a potential novel cause of a Nail-Patella-like disorder.
Jones MC; Topol SE; Rueda M; Oliveira G; Phillips T; Spencer EG; Torkamani A
Genet Med; 2017 Oct; 19(10):1179-1183. PubMed ID: 28383544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
